{"id":24878,"date":"2022-09-13T07:52:52","date_gmt":"2023-12-05T20:37:12","guid":{"rendered":"https:\/\/chilluh.nl\/new-copd-inhaler-2024\/"},"modified":"2022-09-13T07:52:52","modified_gmt":"2023-12-05T20:37:12","slug":"new-copd-inhaler-2024","status":"publish","type":"post","link":"https:\/\/zahid.statichtml.fun\/vyycw-new-copd-inhaler-2024-mybki\/","title":{"rendered":"New Copd Inhaler 2024"},"content":{"rendered":"<div class=\"f96def93ffaa434950dad872b970d56d\" data-index=\"1\" style=\"float: none; margin:10px 0 10px 0; text-align:center;\">\n<div style='text-align: center;'>\r\n<script type=\"text\/javascript\">\r\n\tatOptions = {\r\n\t\t'key' : '47e256568502d808b0f4997433da285b',\r\n\t\t'format' : 'iframe',\r\n\t\t'height' : 250,\r\n\t\t'width' : 300,\r\n\t\t'params' : {}\r\n\t};\r\n\tdocument.write('<scr' + 'ipt type=\"text\/javascript\" src=\"\/\/actressdoleful.com\/47e256568502d808b0f4997433da285b\/invoke.js\"><\/scr' + 'ipt>');\r\n<\/script>\r\n<\/div>\r\n\n<\/div>\n<p><b>New Copd Inhaler 2024<\/b> &#8211; The 2024 report from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD) has been published. . London: GSK plc has announced it will start Phase III trials of a low carbon version of its metered dose inhaler (MDI), Ventolin (salbutamol), using a next generation propellant, in 2024. .<\/p>\n<h2>New Copd Inhaler 2024<\/h2>\n<p align=center> <a https:\/\/lookaside.fbsbx.com\/lookaside\/crawler\/media\/?media_id=744975831002781 title=\"Global Initiative for Chronic Obstructive Lung Disease   GOLD \" alt=\"Global Initiative for Chronic Obstructive Lung Disease   GOLD \"><img decoding=\"async\" src=\"https:\/\/lookaside.fbsbx.com\/lookaside\/crawler\/media\/?media_id=744975831002781\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n<p>Source : <a href=\"https:\/\/www.facebook.com\">www.facebook.com<\/a><\/p>\n<h2>Amazon.com: SAGEKING New 2024 Fashion Alert Stainless Steel Chain <\/h2>\n<p align=center><a https:\/\/m.media-amazon.com\/images\/I\/5123J6xQa4L._AC_UY1000_.jpg title=\"Amazon.com: SAGEKING New 2024 Fashion Alert Stainless Steel Chain \" alt=\"Amazon.com: SAGEKING New 2024 Fashion Alert Stainless Steel Chain \"><img decoding=\"async\" src=\"https:\/\/m.media-amazon.com\/images\/I\/5123J6xQa4L._AC_UY1000_.jpg\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n<p>Source : <a href=\"https:\/\/www.amazon.com\" rel=\"nofollow\">www.amazon.com<\/a><\/p>\n<h2>Medical Society of New Jersey<\/h2>\n<p align=center><a https:\/\/lookaside.fbsbx.com\/lookaside\/crawler\/media\/?media_id=199906828329 title=\"Medical Society of New Jersey\" alt=\"Medical Society of New Jersey\"><img decoding=\"async\" src=\"https:\/\/lookaside.fbsbx.com\/lookaside\/crawler\/media\/?media_id=199906828329\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n<p>Source : <a href=\"https:\/\/www.facebook.com\" rel=\"nofollow\">www.facebook.com<\/a><\/p>\n<h2>A tool to identify NCD interventions to achieve the SDG target <\/h2>\n<p align=center> <a https:\/\/www.thelancet.com\/cms\/asset\/5b6811bf-94e3-495a-953d-c68f3784e29e\/gr1.jpg title=\"A tool to identify NCD interventions to achieve the SDG target \" alt=\"A tool to identify NCD interventions to achieve the SDG target \"><img decoding=\"async\" src=\"https:\/\/www.thelancet.com\/cms\/asset\/5b6811bf-94e3-495a-953d-c68f3784e29e\/gr1.jpg\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n<p>Source : <a href=\"https:\/\/www.thelancet.com\" rel=\"nofollow\">www.thelancet.com<\/a><\/p>\n<h2>Dr Joshua Neale ????????\u200d???? (@Jphneale) \/ X<\/h2>\n<p align=center> <a https:\/\/pbs.twimg.com\/media\/F-ycDIvWoAAj630.jpg title=\"Dr Joshua Neale ????????\u200d???? (@Jphneale) \/ X\" alt=\"Dr Joshua Neale ????????\u200d???? (@Jphneale) \/ X\"><img decoding=\"async\" src=\"https:\/\/pbs.twimg.com\/media\/F-ycDIvWoAAj630.jpg\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n<p>Source : <a href=\"https:\/\/twitter.com\" rel=\"nofollow\">twitter.com<\/a><\/p>\n<h2>A tool to identify NCD interventions to achieve the SDG target <\/h2>\n<p align=center> <a https:\/\/www.thelancet.com\/cms\/attachment\/e6dd736b-dce9-4d3d-aad5-3c723586b4ff\/gr1_lrg.jpg title=\"A tool to identify NCD interventions to achieve the SDG target \" alt=\"A tool to identify NCD interventions to achieve the SDG target \"><img decoding=\"async\" src=\"https:\/\/www.thelancet.com\/cms\/attachment\/e6dd736b-dce9-4d3d-aad5-3c723586b4ff\/gr1_lrg.jpg\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n<p>Source : <a href=\"https:\/\/www.thelancet.com\" rel=\"nofollow\">www.thelancet.com<\/a><\/p>\n<h2>GOLD 2024 COPD Guidelines: What&#8217;s New in It ?   YouTube<\/h2>\n<p align=center> <a https:\/\/i.ytimg.com\/vi\/17RgwLL_rIE\/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&#038;rs=AOn4CLDd_cBHz-5Y_a6vQjm3oXfAk1IvUQ title=\"GOLD 2024 COPD Guidelines: What's New in It ?   YouTube\" alt=\"GOLD 2024 COPD Guidelines: What's New in It ?   YouTube\"><img decoding=\"async\" src=\"https:\/\/i.ytimg.com\/vi\/17RgwLL_rIE\/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&#038;rs=AOn4CLDd_cBHz-5Y_a6vQjm3oXfAk1IvUQ\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n<p>Source : <a href=\"https:\/\/www.youtube.com\" rel=\"nofollow\">www.youtube.com<\/a><\/p>\n<h2>Respiratory Professional Care | Education<\/h2>\n<p align=center> <a https:\/\/lookaside.fbsbx.com\/lookaside\/crawler\/media\/?media_id=100063487423506 title=\"Respiratory Professional Care | Education\" alt=\"Respiratory Professional Care | Education\"><img decoding=\"async\" src=\"https:\/\/lookaside.fbsbx.com\/lookaside\/crawler\/media\/?media_id=100063487423506\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n<p>Source : <a href=\"https:\/\/www.facebook.com\" rel=\"nofollow\">www.facebook.com<\/a><\/p>\n<h2>Digital Dose Inhaler Market Size, Share Analysis Report 2030<\/h2>\n<p align=center> <a https:\/\/www.grandviewresearch.com\/static\/img\/research\/us-digital-dose-inhaler-market.png title=\"Digital Dose Inhaler Market Size, Share Analysis Report 2030\" alt=\"Digital Dose Inhaler Market Size, Share Analysis Report 2030\"><img decoding=\"async\" src=\"https:\/\/www.grandviewresearch.com\/static\/img\/research\/us-digital-dose-inhaler-market.png\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n<p>Source : <a href=\"https:\/\/www.grandviewresearch.com\" rel=\"nofollow\">www.grandviewresearch.com<\/a><\/p>\n<h2>Hyperinflation, COPD screening, smoking cessation among changes in <\/h2>\n<p align=center> <a https:\/\/www.healio.com\/~\/media\/slack-news\/stock-images\/pulmonology\/c\/copd_adobe.jpg?w=800 title=\"Hyperinflation, COPD screening, smoking cessation among changes in \" alt=\"Hyperinflation, COPD screening, smoking cessation among changes in \"><img decoding=\"async\" src=\"https:\/\/www.healio.com\/~\/media\/slack-news\/stock-images\/pulmonology\/c\/copd_adobe.jpg?w=800\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n<p>Source : <a href=\"https:\/\/www.healio.com\" rel=\"nofollow\">www.healio.com<\/a><\/p>\n<p><b>New Copd Inhaler 2024 Global Initiative for Chronic Obstructive Lung Disease   GOLD <\/b>:   The companies behind Dupixent will seek the therapy&#8217;s approval for COPD by year&#8217;s end, after trial data show it reduced patient exacerbations. . GSK announces major step towards sustainability ambitions with advancement of low carbon Ventolin programme to phase III trials: London, UK Wednesday, November 22, 2023, 09:00 Hrs  . <\/p>\n\n<div style=\"font-size: 0px; height: 0px; line-height: 0px; margin: 0; padding: 0; clear: both;\"><\/div>","protected":false},"excerpt":{"rendered":"<p>New Copd Inhaler 2024 &#8211; The 2024 report from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD) has been published. . London: GSK plc has announced it will start Phase III trials of a low carbon version of its metered dose inhaler [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[57],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/zahid.statichtml.fun\/wp-json\/wp\/v2\/posts\/24878"}],"collection":[{"href":"https:\/\/zahid.statichtml.fun\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zahid.statichtml.fun\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zahid.statichtml.fun\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/zahid.statichtml.fun\/wp-json\/wp\/v2\/comments?post=24878"}],"version-history":[{"count":0,"href":"https:\/\/zahid.statichtml.fun\/wp-json\/wp\/v2\/posts\/24878\/revisions"}],"wp:attachment":[{"href":"https:\/\/zahid.statichtml.fun\/wp-json\/wp\/v2\/media?parent=24878"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zahid.statichtml.fun\/wp-json\/wp\/v2\/categories?post=24878"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zahid.statichtml.fun\/wp-json\/wp\/v2\/tags?post=24878"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}